HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaobing Wang Selected Research

Growth Differentiation Factor 15

2/2023GDF15 negatively regulates chemosensitivity via TGFBR2-AKT pathway-dependent metabolism in esophageal squamous cell carcinoma.
1/2018GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer.
4/2017Circulating MIC-1/GDF15 is a complementary screening biomarker with CEA and correlates with liver metastasis and poor survival in colorectal cancer.
1/2016Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer.
8/2014Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaobing Wang Research Topics

Disease

122Neoplasms (Cancer)
05/2024 - 01/2006
29Breast Neoplasms (Breast Cancer)
12/2023 - 01/2007
14Leukemia
04/2016 - 04/2007
11Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 01/2014
10Glioma (Gliomas)
06/2021 - 07/2017
9Neoplasm Metastasis (Metastasis)
05/2024 - 01/2015
9Sarcoma 180
12/2015 - 12/2006
8Alzheimer Disease (Alzheimer's Disease)
08/2023 - 05/2015
7Infections
03/2021 - 11/2013
7Crohn Disease (Crohn's Disease)
01/2017 - 01/2013
6Inflammation (Inflammations)
07/2022 - 01/2016
6Necrosis
02/2022 - 06/2013
6Hepatocellular Carcinoma (Hepatoma)
12/2021 - 01/2008
6Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2017 - 01/2013
4Lung Neoplasms (Lung Cancer)
12/2022 - 07/2017
4Stomach Neoplasms (Stomach Cancer)
12/2022 - 03/2015
4Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 01/2017
4Burns
03/2021 - 01/2017
4Colitis
01/2017 - 01/2014
3Esophageal Squamous Cell Carcinoma
05/2024 - 11/2020
3Adenocarcinoma
03/2024 - 08/2014
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 04/2016
3Parkinson Disease (Parkinson's Disease)
03/2024 - 11/2016
3Ovarian Neoplasms (Ovarian Cancer)
12/2023 - 12/2017
3Triple Negative Breast Neoplasms
12/2023 - 06/2015
3Anemia
01/2023 - 09/2011
3Hypertension (High Blood Pressure)
01/2023 - 07/2010
3Fibrosis (Cirrhosis)
01/2023 - 01/2020
3Non-alcoholic Fatty Liver Disease
01/2023 - 03/2016
3Phototoxic Dermatitis (Phototoxicity)
12/2022 - 11/2014
3COVID-19
07/2022 - 01/2021
3Hypoxia (Hypoxemia)
01/2022 - 01/2021
3Type 2 Diabetes Mellitus (MODY)
08/2021 - 10/2017
3Brain Neoplasms (Brain Tumor)
01/2020 - 01/2019
3Esophageal Neoplasms (Esophageal Cancer)
12/2018 - 01/2014
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2015 - 11/2013
3Leukemia L1210
07/2014 - 04/2011
3Lymphoma (Lymphomas)
05/2011 - 07/2006
2Tertiary Lymphoid Structures
05/2024 - 03/2024
2Portal Hypertension
02/2024 - 12/2023
2Hepatic Encephalopathy
02/2024 - 12/2023

Drug/Important Bio-Agent (IBA)

181-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2022 - 09/2013
18protoporphyrin IXIBA
04/2016 - 12/2006
12Biomarkers (Surrogate Marker)IBA
01/2023 - 08/2014
12sinoporphyrin sodiumIBA
12/2022 - 01/2014
11LigandsIBA
07/2021 - 07/2006
9Proteins (Proteins, Gene)FDA Link
07/2022 - 07/2008
8DNA (Deoxyribonucleic Acid)IBA
05/2024 - 12/2008
8EnzymesIBA
02/2021 - 01/2007
7Indicators and Reagents (Reagents)IBA
01/2023 - 02/2013
7phytochlorinIBA
12/2016 - 11/2013
6Messenger RNA (mRNA)IBA
05/2024 - 01/2012
6Liposomes (Liposome)IBA
06/2021 - 10/2017
6HematoporphyrinsIBA
02/2010 - 01/2008
5Peptides (Polypeptides)IBA
03/2024 - 07/2006
5Growth Differentiation Factor 15IBA
02/2023 - 08/2014
5AntioxidantsIBA
01/2023 - 01/2008
5AntigensIBA
10/2022 - 01/2015
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2022 - 03/2015
5Membrane Proteins (Integral Membrane Proteins)IBA
11/2019 - 07/2008
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 05/2014
4Immune Checkpoint InhibitorsIBA
05/2024 - 05/2021
4Hematoxylin (Haematoxylon)IBA
03/2024 - 01/2015
4Eosine Yellowish-(YS) (Eosin)IBA
03/2024 - 01/2015
4Photosensitizing Agents (Photosensitizers)IBA
12/2022 - 03/2016
4PorphyrinsIBA
05/2021 - 01/2018
4Interleukin-6 (Interleukin 6)IBA
03/2021 - 01/2017
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2021 - 03/2015
3RNA (Ribonucleic Acid)IBA
05/2024 - 01/2020
3ChemokinesIBA
03/2024 - 01/2014
3Hyaluronic Acid (Hyaluronan)IBA
12/2022 - 12/2017
3Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 11/2013
3Amyloid (Amyloid Fibrils)IBA
01/2022 - 01/2018
3Therapeutic UsesIBA
10/2021 - 07/2016
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
06/2021 - 11/2017
3Glucose (Dextrose)FDA LinkGeneric
05/2021 - 10/2017
3LipidsIBA
03/2021 - 03/2008
3CytokinesIBA
01/2021 - 01/2017
3Small Interfering RNA (siRNA)IBA
08/2020 - 06/2015
3asiaticosideIBA
01/2020 - 02/2018
3Doxorubicin (Adriamycin)FDA LinkGeneric
11/2019 - 11/2014
3Chloroform (Trichloromethane)IBA
01/2017 - 08/2012
3Antineoplastic Agents (Antineoplastics)IBA
11/2016 - 11/2013
3coumarinIBA
04/2016 - 07/2010
3Actins (F Actin)IBA
03/2016 - 03/2008
2Cell-Free Nucleic AcidsIBA
05/2024 - 10/2020
2Glycoproteins (Glycoprotein)IBA
03/2024 - 01/2018

Therapy/Procedure

86Therapeutics
05/2024 - 07/2006
20Drug Therapy (Chemotherapy)
01/2022 - 12/2008
19Photochemotherapy (Photodynamic Therapy)
12/2022 - 09/2013
10Precision Medicine
01/2024 - 01/2015
8Lasers (Laser)
12/2022 - 08/2014
6Immunotherapy
05/2024 - 01/2021
4Ultrasonic Therapy
09/2021 - 02/2009
4Aftercare (After-Treatment)
01/2020 - 11/2014
3Phototherapy (Light Therapy)
10/2022 - 01/2019
3Photothermal Therapy
06/2021 - 11/2017
3Microbubbles
11/2016 - 11/2014
2Surgical Portasystemic Shunt (Portosystemic Shunt)
02/2024 - 12/2023
2Transjugular Intrahepatic Portasystemic Shunt
02/2024 - 12/2023